BASILEO, Michela
 Distribuzione geografica
Continente #
NA - Nord America 2.466
AS - Asia 1.747
EU - Europa 1.546
SA - Sud America 268
AF - Africa 29
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.060
Nazione #
US - Stati Uniti d'America 2.356
SG - Singapore 744
IE - Irlanda 324
UA - Ucraina 301
HK - Hong Kong 255
CN - Cina 251
VN - Vietnam 230
BR - Brasile 221
RU - Federazione Russa 219
DE - Germania 137
IT - Italia 132
FI - Finlandia 118
FR - Francia 97
CA - Canada 79
SE - Svezia 62
GB - Regno Unito 59
TR - Turchia 53
KR - Corea 42
IN - India 41
BE - Belgio 25
BD - Bangladesh 24
MX - Messico 19
LB - Libano 17
JP - Giappone 12
PL - Polonia 12
AR - Argentina 11
NL - Olanda 11
SA - Arabia Saudita 11
AT - Austria 10
EC - Ecuador 10
PK - Pakistan 10
UZ - Uzbekistan 10
CH - Svizzera 9
ES - Italia 8
IQ - Iraq 8
CO - Colombia 7
CZ - Repubblica Ceca 7
TN - Tunisia 7
CL - Cile 6
ID - Indonesia 6
LT - Lituania 6
ZA - Sudafrica 6
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
OM - Oman 4
AZ - Azerbaigian 3
JO - Giordania 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AU - Australia 2
CG - Congo 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
NI - Nicaragua 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LK - Sri Lanka 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 6.060
Città #
Singapore 538
Chandler 397
Dublin 324
San Jose 259
Hong Kong 254
Jacksonville 166
San Mateo 166
Dong Ket 165
Ashburn 141
Santa Clara 87
Boardman 82
Moscow 80
Beijing 77
Medford 71
Princeton 71
Ann Arbor 70
Lauterbourg 67
Ottawa 60
Munich 56
Andover 49
Wilmington 42
Izmir 37
Helsinki 36
São Paulo 28
Orem 27
Los Angeles 26
New York 26
Seoul 26
Ho Chi Minh City 23
Perugia 22
Saint Petersburg 21
Altamura 16
Brussels 16
Norwalk 15
Dongjak-gu 14
Hanoi 14
Des Moines 13
Genoa 13
Lawrence 13
Brooklyn 12
London 12
Tokyo 12
Columbus 11
Falls Church 11
Turku 11
Boston 9
Chennai 9
Chicago 9
Denver 9
Houston 9
Mexico City 9
Montreal 9
Redwood City 9
The Dalles 9
Frankfurt am Main 8
Amsterdam 7
Piscataway 7
Warsaw 7
Dhaka 6
Longueville 6
Nuremberg 6
Rio de Janeiro 6
San Francisco 6
Ankara 5
Atlanta 5
Biên Hòa 5
Manchester 5
Medellín 5
Medina 5
Porto Alegre 5
Redmond 5
Sorocaba 5
Stockholm 5
Tashkent 5
Belo Horizonte 4
Bologna 4
Brasília 4
Dallas 4
Itaquaquecetuba 4
Kuala Lumpur 4
Lima 4
Milan 4
Muscat 4
Rome 4
Seattle 4
Tunis 4
Zhengzhou 4
Amman 3
Baghdad 3
Baku 3
Barnet 3
Bastia umbra 3
Belfiore 3
Buffalo 3
Calgary 3
Campinas 3
Cape Town 3
Carapicuíba 3
Caxias do Sul 3
Charlotte 3
Totale 3.963
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 143
Diagnosi molecolare di sepsi: impiego della PCR Real-Time 132
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 125
Influenza vaccination in patients on long-term anticoagulant therapy. 122
Influenza vaccination in patients on long-term anticoagulant therapy 122
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 118
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 118
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 117
Annually repeated influenza vaccination and humoral response in elderly volunteers. 114
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 111
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 110
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 109
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 108
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 108
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 108
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 106
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 106
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 105
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 104
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 102
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 101
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 101
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 101
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 99
The good use of plasma. A critical analysis of five international guidelines. 99
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 98
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 97
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 95
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 92
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 92
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 91
Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. 91
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 90
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 90
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 89
Computer assisted vka monitoring with point of care device by general practitioners. 88
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 84
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 84
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 84
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 83
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 83
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 81
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 80
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 80
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 78
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 76
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 74
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 70
Fresh Frozen Plasma Transfusion Practice: A Regional Benchmark Study. 68
AUDIT OF THE CLINICAL USE OF FRESH-FROZEN PLASMA IN UMBRIA: STUDY DESIGN AND RESULTS. 68
Sorveglianza delle paralisi flaccide acute nella regione Umbria 67
CLINICAL AUDIT OF THE USE OF FRESH FROZEN PLASMA IN UMBRIA. 66
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 66
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 65
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 65
The good use of plasma. A critical analysis of five international guidelines. 63
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 63
COMPUTER ASSISTED VKA MONITORING WITH POINT OF CARE DEVICE BY GENERAL PRACTITIONERS. 63
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 63
Preliminary survey of human intestinal parasitosis in a Peruvian Andean zone 61
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 61
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 61
INTERNATIONAL GUIDELINES ABOUT CLINICAL USE OF FRESH FROZEN PLASMA: A CRITICAL APPRAISAL. 60
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 59
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 59
Il processo di validazione clinica di un algoritmo computerizzato per il monitoraggio della TAO 58
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 58
INHIBITOR DEVELOPMENT IN MILD HAEMOPHILIA A: COULD INFLUENZA VACCINATION HAVE BEEN THE TRIGGER? 56
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 55
Sondaggio conoscitivo coproparassitologico in una zona andina della Cordillera Blanca, Peru'. 51
PROSPECTIVE ASSESSMENT OF CLINICAL ENDPOINTS OF VKA TREATMENT IN A PRIMARY CARE COMPUTER ASSISTED MANAGEMENT MODEL 49
Totale 6.164
Categoria #
all - tutte 25.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 0 0 0 0 11 50 169
2021/2022512 5 101 1 12 22 8 6 213 6 10 57 71
2022/20231.072 75 102 9 102 106 111 0 63 442 5 36 21
2023/2024438 28 42 28 9 3 0 141 20 39 5 63 60
2024/2025966 11 90 32 54 161 44 49 24 177 69 171 84
2025/20261.929 144 130 51 234 281 193 339 97 306 154 0 0
Totale 6.164